Episode
GLP-1s, Diabetes, and Why the Weight Loss Came Second w/ Christa Brown, RD
- Published
- May 7, 2026
- Duration seconds
- 2010
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/glp-1-hub-support-community-and-weight-loss-7228656/episodes/glp-1s-diabetes-and-why-the-weight-loss-came-second-w-christa-brown-rd/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/glp-1-hub-support-community-and-weight-loss-7228656/glp-1s-diabetes-and-why-the-weight-loss-came-second-w-christa-brown-rd.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Send us Fan Mail Before Ozempic was a weight-loss story, it was a diabetes drug - and at diabetes doses, it behaves nothing like the version you've heard about. Registered dietitian Ana Reisdorf sits down with diabetes specialist Christa Brown, RD, to unpack what GLP-1s actually do for type 2 diabetes - and why they rarely cause the blood sugar crashes other diabetes meds do. They cover dosing, A1C, nutrition, and the lifestyle pieces still doing real work alongside the medication. IN THIS ...